$1.11
0.043.74%
At close: -
$1.10
-0.01-0.90%
After Hours: 4:35 PM EDT
Immunic reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunic using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.24 | $-0.22 | -9.09 % |
Jun 2024 | 2024-08-08 | $-0.21 | $-0.23 | 8.70 % |
Mar 2024 | 2024-05-08 | $-0.30 | $-0.26 | -15.4 % |
Dec 2023 | 2024-02-22 | $-0.48 | $-0.51 | 5.88 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Immunic (IMUX) is scheduled to report earnings on February 20, 2025. The last reported earnings were for reported on November 7, 2024 for Q3.
The Actual EPS was $-0.24, which missed the estimate of $-0.22.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.